Search results
Here's What This Drug News Could Mean for AbbVie's Shareholders
Motley Fool· 2 years agoOn May 11, AbbVie (NYSE: ABBV) announced positive top-line results in its phase 3 clinical trial of...
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool· 2 years agoThe European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently...
Good news for consumers, bad news for North Chicago-based AbbVie as its blockbuster drug Humira...
Chicago Tribune via Yahoo News· 1 year agoOne of the most popular prescription medications in the world is about to face fierce competition in the U.S. — something that could mean lower prices for the drug but a difficult coming year ...
